RECRUITING

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

Talk to us

Conditions

Cystic Fibrosis (CF)Cystic FibrosisChildrenMental health screeningDepressionAnxietyCFTR modulatorsNeuropsychiatric adverse events

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).

Official Title

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

Quick Facts

Study Start:2025-06-02
Study Completion:2028-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07048574

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Months to 11 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. Child with a diagnosis of Cystic fibrosis (CF) actively followed by the CF care team at a participating site
  2. 2. Child is age 18 months thru 11 years
  3. 3. English and/or Spanish speaking
  4. 4. Parent/legal guardian willing and able to give informed consent, and for minor participants ages 7 thru 11 years able to give assent.
  1. * Unable or unwilling to participate in study procedures, or at Site PI discretion.

Contacts and Locations

Study Contact

Beth A Smith, MD
CONTACT
716-898-5940
balucas@buffalo.edu
Minu Mohan, MPH
CONTACT
minuponn@buffalo.edu

Study Locations (Sites)

Children's Hospital of Orange County
Orange, California, 92868
United States
Children's Hospital Colorado
Aurora, Colorado, 80045
United States
Joe DiMaggio
Hollywood, Florida, 33021
United States
Nemours Foundation
Orlando, Florida, 32827
United States
Indiana University
Bloomington, Indiana, 47405
United States
Massachusetts General Hospital
Boston, Massachusetts, 02114
United States
University at Buffalo
Buffalo, New York, 14215
United States
University of North Carolina School of Medicine
Chapel Hill, North Carolina, 27599
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
United States
Brown University Health
Providence, Rhode Island, 02903
United States
UT Southwestern
Plano, Texas, 75235
United States
Children's Hospital of Richmond at Virginia Commonwealth University
Richmond, Virginia, 23219
United States
Seattle Children's Hospital
Seattle, Washington, 98105
United States

Collaborators and Investigators

Sponsor: State University of New York at Buffalo

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-02
Study Completion Date2028-06-30

Study Record Updates

Study Start Date2025-06-02
Study Completion Date2028-06-30

Terms related to this study

Keywords Provided by Researchers

  • Cystic Fibrosis
  • Children
  • Mental health screening
  • Depression
  • Anxiety
  • CFTR modulators
  • Neuropsychiatric adverse events

Additional Relevant MeSH Terms

  • Cystic Fibrosis (CF)